Key result
ABI <0.70 linked to ~190% greater odds of severe atherosclerosis, unlike CRP and central augmentation index.
Why the study?
The ability of ankle brachial index, C-reactive protein, and central augmentation index to identify individuals with severe atherosclerosis in the general population was examined.
Do ankle brachial index, C-reactive protein, and central augmentation index identify individuals with severe atherosclerosis in the general population?
Population
4159 randomly sampled individuals from the Danish general population, including 250 with severe atherosclerosis
Comparison
Ankle brachial index, C-reactive protein, and central augmentation index measurements
Design
Cross-sectional study
Authors
Loading...
ABI <0.9 identifies severe atherosclerosis in the general population; leaves open incremental diagnostic value of CRP or augmentation index.
Cross-Sectional (n=4,159)
Do ankle brachial index, C-reactive protein, and central augmentation index identify individuals with severe atherosclerosis in the general population?
Odds Ratio: 2.9 (95% CI 1.9–4.6)
p-value: p=0.00000003
Ankle brachial index <0.9 is a useful clinical tool to identify individuals with severe atherosclerosis in the general population, whereas categorical CRP and central augmentation index are less useful.
Eldrup et al. (2005) conducted a cross-sectional in Severe atherosclerosis (n=4,159). Ankle brachial index <0.70 vs. Ankle brachial index 0.91-1.10 was evaluated on Severe atherosclerosis (OR 2.9, 95% CI 1.9-4.6, p=0.00000003). Ankle brachial index <0.70 identified individuals with severe atherosclerosis (OR 2.9; 95% CI 1.9-4.6), whereas categorical C-reactive protein and central augmentation index did not.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: